HEALTH

Sale of McKesson Expected: The San Francisco-based drug and managed-care health company is likely to be bought soon in a $5-billion deal by either Glaxo Holdings or Johnson & Johnson in a deal with Glaxo, sources said. Analysts say the deal could take place as soon as this weekend. In anticipation of a takeover, McKesson stock closed up $3.375 at $84.75 after gaining $8.625 on Thursday. Rumors pegged the bidding as high as $125 a share. Bear Stearns analyst Scott Shevick said he believed Glaxo might acquire McKesson after the possible resolution of tax issues that had been holding up the deal.